V. Nekkanti
Acta Pharmaceutica Sinica B · 2015
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from V. Nekkanti's perspective
Ordered by how strongly the researchers V. Nekkanti trusts endorse each paper. Same corpus, a different order for every researcher.
- Amorphous pharmaceutical solids: preparation, characterization and stabilization. (Advanced Drug Delivery Reviews)
- Amphiphilic block copolymers for drug delivery. (Journal of Pharmacy and Science)
- Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)
- What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
- Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. (International journal of pharmaceutics)
- Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
- Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. (Nano letters (Print))
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines (Journal of drug targeting (Print))
- In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. (Journal of Controlled Release)
- A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). (Journal of magnetic resonance (San Diego, Calif. 1997 : Print))
Their papers
- Insoluble drug delivery strategies: review of recent advances and business prospects (2015) — 1,239 citations